Stimuvax Articles

Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC

16 May 2013

Merck Serono NSCLC vaccine candidate fails to meet primary endpoint in Ph III

20 December 2012

Merck Serono and Ono Pharma collaborate on investigational oral MS drug and cancer vaccine

4 October 2011

Merck Serono resumes Stimuvax trials in lung cancer vaccine as FDA lifts clinical hold

18 June 2010

Merck KGaA pleased with Millipore buy, plans resubmission for cladribine and updates on Stimuvax

12 April 2010

Merck KGaA temporarily suspends cancer vaccine Stimuvax clinical program due to case of encephalitis

23 March 2010

Showing 1-6 of 6 articles

Go to beginning

Previous

1

Next

Go to end